circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3

• Main Authors: Haoli Yin (Author), Haixiang Qin (Author), Lei Yang (Author), Mengxia Chen (Author), Yang Yang (Author), Wenlong Zhang (Author), Jiange Hao (Author), Qun Lu (Author), Jingyan Shi (Author), Junlong Zhuang (Author), Xuefeng Qiu (Author), Hongqian Guo (Author)
• Format: Book
• Published: BMC, 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Docetaxel (DTX) is the most widely prescribed first-line chemotherapy for advanced prostate cancer (PCa). Unfortunately, DTX resistance invariably emerges, leading to worse prognosis of PCa. Growing evidence has shown that circRNAs had complex spatiotemporal specificity during th...